Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd   Report issue

For profit Phase 3
Founded: Chengdu China (1999)

Organization Overview

First Clinical Trial
2014
NCT02136342
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorogenic acid (5 trials)

lomustine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 1)

Lung Neoplasms (Phase 2)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2